trial or observed group · 2011 · landmark
Not counted. An animal or lab study.
“They provide a fully independent replication to show that rapamycin can extend mouse life span in males and females, and they show that the effect does not depend on the age at which drug exposure is begun, at least between 9 and 20 months of age.”
Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci
Who: genetically heterogeneous UM-HET3 mice, male and female, at three test sites (TJL, UM, UT)
PMID 20974732
other primary study · 2012 · landmark
Not counted. An animal or lab study.
“Rapamycin started at 20 months of age produces equivalent lifespan extension, in UM-HET3 mice, as it does when started at 9 months of age, and it may prove that the optimal ratio of benefit to harmful side effects will involve starting the drug in mice older than 9 months or may require an intermittent schedule in which months without drug exposure are alternated with months in which rapamycin is provided.”
Rapamycin slows aging in mice. Aging Cell
Who: genetically heterogeneous UM-HET3 mice, both sexes
PMID 22587563
pooled analysis · 2025
Not counted. An animal or lab study.
“Overall, this study suggests that rapamycin and DR confer comparable lifespan extension across a broad range of vertebrates.”
Rapamycin, Not Metformin, Mirrors Dietary Restriction-Driven Lifespan Extension in Vertebrates: A Meta-Analysis. Aging Cell
Who: vertebrates (mostly mice, also rats, monkeys, dogs, fish) in lifespan studies
PMID 40532901